Vairavan Latha, SVP and Chief Financial Officer of Arcutis Biotherapeutics ($ARQT), made five open market sales of company shares over the past year, totaling about $109,000. Her most recent sale occurred on March 2, 2026. These transactions rank 9,440th among 11,678 individual insiders by sale value, well below the average of $8.6 million across 6.4 transactions per insider. She reported no open market purchases.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb. 27, 2026 | Arcutis Biotherapeutics, Inc. | $ARQT | Vairavan Latha | SVP Chief Financial Officer | A | Common Stock | 27000 | $0.00 | 90,607.0000 | 132,885,000 | 42.45% | 0.02% |
| Feb. 27, 2026 | Arcutis Biotherapeutics, Inc. | $ARQT | Vairavan Latha | SVP Chief Financial Officer | A | Stock Option (right to buy) | 70000 | $0.00 | 70,000.0000 | 132,885,000 | 9999.99% | 0.05% |
| March 2, 2026 | Arcutis Biotherapeutics, Inc. | $ARQT | Vairavan Latha | SVP Chief Financial Officer | S | Common Stock | 81 | $25.91 | 87,754.0000 | 132,885,000 | 0.09% | 0.00% |
| March 2, 2026 | Arcutis Biotherapeutics, Inc. | $ARQT | Vairavan Latha | SVP Chief Financial Officer | S | Common Stock | 2772 | $25.16 | 87,835.0000 | 132,885,000 | 3.06% | 0.00% |
| Feb. 2, 2026 | Arcutis Biotherapeutics, Inc. | $ARQT | Vairavan Latha | SVP Chief Financial Officer | S | Common Stock | 1320 | $25.50 | 63,607.0000 | 132,885,000 | 2.03% | 0.00% |
| Nov. 3, 2025 | Arcutis Biotherapeutics, Inc. | $ARQT | Vairavan Latha | SVP Chief Financial Officer | S | Common Stock | 88 | $24.72 | 64,927.0000 | 132,885,000 | 0.14% | 0.00% |
| Aug. 4, 2025 | Arcutis Biotherapeutics, Inc. | $ARQT | Vairavan Latha | SVP Chief Financial Officer | S | Common Stock | 89 | $14.33 | 65,015.0000 | 120,957,633 | 0.14% | 0.00% |
| May 6, 2025 | Arcutis Biotherapeutics, Inc. | $ARQT | Vairavan Latha | SVP Chief Financial Officer | A | Stock Option (right to buy) | 60000 | $0.00 | 60,000.0000 | 120,957,633 | 9999.99% | 0.05% |
| May 6, 2025 | Arcutis Biotherapeutics, Inc. | $ARQT | Vairavan Latha | SVP Chief Financial Officer | A | Common Stock | 20000 | $0.00 | 65,104.0000 | 120,957,633 | 44.34% | 0.02% |